Pooled sera from AZD1222 vaccinees demonstrates a broad neutralizing antibody response against SARS-CoV-2 variants of concern
infections
INFECTIONS
nAb responses have been proposed as a SARS-CoV-2 correlate of protection across multiple vaccine platforms (To provide context for this analysis of breakthrough infections, we assessed nAbs elicited against contemporary variants of concern (VoCs) using pooled sera obtained from vaccinees (